
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension
David Fulton, Xueyi Li, Zsuzsanna Bordán, et al.
Antioxidants and Redox Signaling (2019) Vol. 31, Iss. 14, pp. 1053-1069
Open Access | Times Cited: 46
David Fulton, Xueyi Li, Zsuzsanna Bordán, et al.
Antioxidants and Redox Signaling (2019) Vol. 31, Iss. 14, pp. 1053-1069
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Twist1 regulates macrophage plasticity to promote renal fibrosis through galectin-3
Qingfeng Wu, Shiren Sun, Wei Lei, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 51
Qingfeng Wu, Shiren Sun, Wei Lei, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 51
Galectin-3: therapeutic targeting in liver disease
Alison C. MacKinnon, Dimitar Tonev, Brian Jacoby, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 9, pp. 779-791
Open Access | Times Cited: 22
Alison C. MacKinnon, Dimitar Tonev, Brian Jacoby, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 9, pp. 779-791
Open Access | Times Cited: 22
Unraveling the role of galectin-3 in cardiac pathology and physiology
Ignacio M. Seropián, Pablo Cassaglia, Verónica Miksztowicz, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 17
Ignacio M. Seropián, Pablo Cassaglia, Verónica Miksztowicz, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 17
Melatonin ameliorates bleomycin-induced pulmonary fibrosis via activating NRF2 and inhibiting galectin-3 expression
Yue‐Jiao Lan, Ming-Han Cheng, Hui-min Ji, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 5, pp. 1029-1037
Open Access | Times Cited: 28
Yue‐Jiao Lan, Ming-Han Cheng, Hui-min Ji, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 5, pp. 1029-1037
Open Access | Times Cited: 28
Hypoxia activates GPR146 which participates in pulmonary vascular remodeling by promoting pyroptosis of pulmonary artery endothelial cells
Yanjiao Jiang, Jie Huang, Yu Xia, et al.
European Journal of Pharmacology (2023) Vol. 941, pp. 175502-175502
Open Access | Times Cited: 14
Yanjiao Jiang, Jie Huang, Yu Xia, et al.
European Journal of Pharmacology (2023) Vol. 941, pp. 175502-175502
Open Access | Times Cited: 14
Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension
Fjodor Bekedam, Marie‐José Goumans, Harm Jan Bogaard, et al.
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108389-108389
Open Access | Times Cited: 14
Fjodor Bekedam, Marie‐José Goumans, Harm Jan Bogaard, et al.
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108389-108389
Open Access | Times Cited: 14
Mycobacterium tuberculosis Reactivates HIV-1 via Exosome-Mediated Resetting of Cellular Redox Potential and Bioenergetics
Priyanka Tyagi, Virender Kumar Pal, Ragini Agrawal, et al.
mBio (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 33
Priyanka Tyagi, Virender Kumar Pal, Ragini Agrawal, et al.
mBio (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 33
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases
Pratima Nangia‐Makker, Victor Hogan, Vitaly Balan, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 12, pp. 102622-102622
Open Access | Times Cited: 20
Pratima Nangia‐Makker, Victor Hogan, Vitaly Balan, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 12, pp. 102622-102622
Open Access | Times Cited: 20
Single Cell High Dimensional Analysis of Human Peripheral Blood Mononuclear Cells Reveals Unique Intermediate Monocyte Subsets Associated with Sex Differences in Coronary Artery Disease
Nandini Chatterjee, Ravi K. Komaravolu, Christopher P. Durant, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2894-2894
Open Access | Times Cited: 4
Nandini Chatterjee, Ravi K. Komaravolu, Christopher P. Durant, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2894-2894
Open Access | Times Cited: 4
Mechanism of pulmonary arterial vascular cell dysfunction in pulmonary hypertension in broiler chickens
Juan Chen, Chenxi Jiang, Xiaoqin Hu, et al.
Avian Pathology (2025), pp. 1-12
Closed Access
Juan Chen, Chenxi Jiang, Xiaoqin Hu, et al.
Avian Pathology (2025), pp. 1-12
Closed Access
Danshensu Derivatives: A Series of Promising Drugs With Protective Effects Against Cardiocerebrovascular Diseases and Cancers
Yang Yang, Luyang Du, Huadong Zhao, et al.
Medicinal Research Reviews (2025)
Closed Access
Yang Yang, Luyang Du, Huadong Zhao, et al.
Medicinal Research Reviews (2025)
Closed Access
Effects of Troxerutin on Oxidative Stress, Inflammation and Galectin- 3 Expression in Intracerebroventricular Kainic Acid-Induced Neurotoxicity
Mehmet Demir, Hülya Elbe, Dilan ÇETİNAVCI, et al.
Inflammation (2025)
Open Access
Mehmet Demir, Hülya Elbe, Dilan ÇETİNAVCI, et al.
Inflammation (2025)
Open Access
Androgen receptor inhibitor ameliorates pulmonary arterial hypertension by enhancing the apoptosis level through suppressing the Notch3/Hes5 pathway
Jiayan Sun, Jiancheng Lin, Di Yin, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Jiayan Sun, Jiancheng Lin, Di Yin, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Activation of AMPK inhibits Galectin-3-induced pulmonary artery smooth muscle cells proliferation by upregulating hippo signaling effector YAP
Qianqian Zhang, Wenge Li, Yanting Zhu, et al.
Molecular and Cellular Biochemistry (2021)
Closed Access | Times Cited: 23
Qianqian Zhang, Wenge Li, Yanting Zhu, et al.
Molecular and Cellular Biochemistry (2021)
Closed Access | Times Cited: 23
Galectin-3 as TREM2 upstream factor contributes to lung ischemia-reperfusion injury by regulating macrophage polarization
Hao Liu, Lu Zhang, Zhen Liu, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107496-107496
Open Access | Times Cited: 8
Hao Liu, Lu Zhang, Zhen Liu, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107496-107496
Open Access | Times Cited: 8
Galectin-3 Mediates Vascular Dysfunction in Obesity by Regulating NADPH Oxidase 1
Caleb A. Padgett, Róbert Bátori, Andrew C. Speese, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 10
Open Access | Times Cited: 8
Caleb A. Padgett, Róbert Bátori, Andrew C. Speese, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 10
Open Access | Times Cited: 8
Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
Mohammadjavad Sotoudeheian
Protein and Peptide Letters (2024) Vol. 31, Iss. 4, pp. 290-304
Closed Access | Times Cited: 3
Mohammadjavad Sotoudeheian
Protein and Peptide Letters (2024) Vol. 31, Iss. 4, pp. 290-304
Closed Access | Times Cited: 3
Srolo Bzhtang reduces inflammation and vascular remodeling via suppression of the MAPK/NF-κB signaling pathway in rats with pulmonary arterial hypertension
Tingting Chen, Shanshan Su, Zhanting Yang, et al.
Journal of Ethnopharmacology (2022) Vol. 297, pp. 115572-115572
Closed Access | Times Cited: 14
Tingting Chen, Shanshan Su, Zhanting Yang, et al.
Journal of Ethnopharmacology (2022) Vol. 297, pp. 115572-115572
Closed Access | Times Cited: 14
Evaluation of right ventricular diastolic function, systolic function, and circulating galectin‐3 concentrations in dogs with pulmonary stenosis
Randolph L. Winter, Kara L. Maneval, Claudio Serrano Ferrel, et al.
Journal of Veterinary Internal Medicine (2023) Vol. 37, Iss. 6, pp. 2030-2038
Open Access | Times Cited: 7
Randolph L. Winter, Kara L. Maneval, Claudio Serrano Ferrel, et al.
Journal of Veterinary Internal Medicine (2023) Vol. 37, Iss. 6, pp. 2030-2038
Open Access | Times Cited: 7
Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension
Yifan Zuo, Boyang Li, Minglang Gao, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Yifan Zuo, Boyang Li, Minglang Gao, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
A peripheral system disease—Pulmonary hypertension
Yang Sun, Chen Chen, Yan Qian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116787-116787
Open Access | Times Cited: 2
Yang Sun, Chen Chen, Yan Qian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116787-116787
Open Access | Times Cited: 2
Novel Tryptophan Hydroxylase Inhibitor TPT-001 Reverses PAH, Vascular Remodeling, and Proliferative-Proinflammatory Gene Expression
Ekaterina Legchenko, Philippe Chouvarine, Fatimunnisa Qadri, et al.
JACC Basic to Translational Science (2024) Vol. 9, Iss. 7, pp. 890-902
Open Access | Times Cited: 2
Ekaterina Legchenko, Philippe Chouvarine, Fatimunnisa Qadri, et al.
JACC Basic to Translational Science (2024) Vol. 9, Iss. 7, pp. 890-902
Open Access | Times Cited: 2
The Glycobiology of Pulmonary Arterial Hypertension
Shia Vang, Phillip Cochran, Julio Sebastian Domingo, et al.
Metabolites (2022) Vol. 12, Iss. 4, pp. 316-316
Open Access | Times Cited: 11
Shia Vang, Phillip Cochran, Julio Sebastian Domingo, et al.
Metabolites (2022) Vol. 12, Iss. 4, pp. 316-316
Open Access | Times Cited: 11
Inhibition of galectin-3 ameliorates high-glucose-induced oxidative stress and inflammation in ARPE-19 cells
Min Li, Meimei Tian, Xinli Jiang, et al.
Cutaneous and Ocular Toxicology (2022) Vol. 41, Iss. 2, pp. 179-186
Closed Access | Times Cited: 11
Min Li, Meimei Tian, Xinli Jiang, et al.
Cutaneous and Ocular Toxicology (2022) Vol. 41, Iss. 2, pp. 179-186
Closed Access | Times Cited: 11
The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan
Jerzy Maksymowicz, Anna Palko-Łabuz, Beata Sobieszczańska, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 732-732
Open Access | Times Cited: 9
Jerzy Maksymowicz, Anna Palko-Łabuz, Beata Sobieszczańska, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 732-732
Open Access | Times Cited: 9